These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15324809)

  • 21. A novel mammalian display system for the selection of protein-protein interactions by decoy receptor engagement.
    Ellmark P; Ohlin M; Borrebaeck CA; Furebring C
    J Mol Recognit; 2004; 17(4):316-22. PubMed ID: 15227638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic engineering, expression, and activity of a chimeric monoclonal antibody-avidin fusion protein for receptor-mediated delivery of biotinylated drugs in humans.
    Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
    Bioconjug Chem; 2008 Mar; 19(3):731-9. PubMed ID: 18278853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell targeted phagemid rescued by preselected landscape phage.
    Mount JD; Samoylova TI; Morrison NE; Cox NR; Baker HJ; Petrenko VA
    Gene; 2004 Oct; 341():59-65. PubMed ID: 15474288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting of polyplexes: toward synthetic virus vector systems.
    Wagner E; Culmsee C; Boeckle S
    Adv Genet; 2005; 53():333-54. PubMed ID: 16241000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface.
    Li D; Wang QQ; Tang GP; Huang HL; Shen FP; Li JZ; Yu H
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):906-11. PubMed ID: 17048306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
    Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting solid tumors via T cell receptor complementarity-determining region 3delta in an engineered antibody.
    Wang Z; Zhang T; Hu H; Zhang H; Yang Z; Cui L; He W
    Cancer Lett; 2008 Dec; 272(2):242-52. PubMed ID: 18782650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From combinatorial chemistry to cancer-targeting peptides.
    Aina OH; Liu R; Sutcliffe JL; Marik J; Pan CX; Lam KS
    Mol Pharm; 2007; 4(5):631-51. PubMed ID: 17880166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and construction of targeted AAVP vectors for mammalian cell transduction.
    Hajitou A; Rangel R; Trepel M; Soghomonyan S; Gelovani JG; Alauddin MM; Pasqualini R; Arap W
    Nat Protoc; 2007; 2(3):523-31. PubMed ID: 17406616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineered chimeric enzymes as tools for drug discovery: generating reliable bacterial screens for the detection, discovery, and assessment of estrogen receptor modulators.
    Skretas G; Meligova AK; Villalonga-Barber C; Mitsiou DJ; Alexis MN; Micha-Screttas M; Steele BR; Screttas CG; Wood DW
    J Am Chem Soc; 2007 Jul; 129(27):8443-57. PubMed ID: 17569534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
    Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
    Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bifunctional antibody-Renilla luciferase fusion protein for in vivo optical detection of tumors.
    Venisnik KM; Olafsen T; Loening AM; Iyer M; Gambhir SS; Wu AM
    Protein Eng Des Sel; 2006 Oct; 19(10):453-60. PubMed ID: 16882674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of a recombinant bifunctional protein from a chimera of human lutropin receptor and human chorionic gonadotropin beta-subunit.
    Hao M; Rathnam P; Saxena B
    J Reprod Immunol; 2004 Oct; 63(2):123-35. PubMed ID: 15380943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.
    Campos SK; Barry MA
    Virology; 2006 Jun; 349(2):453-62. PubMed ID: 16504233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient isolation of peptide ligands for the endothelial cell protein C receptor (EPCR) using candidate receptor phage display biopanning.
    White SJ; Simmonds RE; Lane DA; Baker AH
    Peptides; 2005 Jul; 26(7):1264-9. PubMed ID: 15949645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simplified characterization through site-specific protease-mediated release of affinity proteins selected by staphylococcal display.
    Kronqvist N; Löfblom J; Severa D; Ståhl S; Wernérus H
    FEMS Microbiol Lett; 2008 Jan; 278(1):128-36. PubMed ID: 18034830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
    McQuade P; Knight LC; Welch MJ
    Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand depletion negatively controls the mitogenic activity of epidermal growth factor.
    van de Poll ML; van Rotterdam W; Gadellaa MM; Jacobs-Oomen S; van Zoelen EJ
    Exp Cell Res; 2005 Apr; 304(2):630-41. PubMed ID: 15748906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of targeting ligand flexibility on receptor binding of particulate drug delivery systems.
    Olivier V; Meisen I; Meckelein B; Hirst TR; Peter-Katalinic J; Schmidt MA; Frey A
    Bioconjug Chem; 2003; 14(6):1203-8. PubMed ID: 14624636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Display of aggregation-prone ligand binding domain of human PPAR gamma on surface of bacteriophage lambda.
    Kong B; Ma WJ
    Acta Pharmacol Sin; 2006 Jan; 27(1):91-9. PubMed ID: 16364215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.